Matthias Aizenberg

Matthias Aizenberg

Healthcare Innovation Consultant
Matthias Aizenberg is a seasoned expert in the Healthcare industry. He explores digital health, clinical processes, and healthcare management strategies. Matthias has a deep interest in pharmaceutical and healthcare innovation and is a well-trusted resource for biopharma professionals.
How Do State Privacy Laws Evolve Across the US?
Management & Regulatory How Do State Privacy Laws Evolve Across the US?

The swift advancement of technology has raised significant concerns about the protection of personal data. In response, the United States is seeing an increasingly diverse collection of state-enacted privacy laws. With federal action lagging, individual states are crafting their own regulatory

Is the DEA Stalling Cannabis Research through Bureaucracy?
Management & Regulatory Is the DEA Stalling Cannabis Research through Bureaucracy?

The pursuit of understanding the medical benefits of cannabis continues to evolve as researchers like those at MMJ BioPharma Cultivation Inc. face significant bureaucratic resistance, particularly from federal institutions such as the DEA. The company’s recent lawsuit highlights the extensive

How Is Exblifep Reinventing UTI and Pneumonia Treatment?
Management & Regulatory How Is Exblifep Reinventing UTI and Pneumonia Treatment?

The realm of antibiotic therapy is witnessing a remarkable transformation with the UK's MHRA's endorsement of Exblifep, a novel medical intervention for the management of sophisticated urinary tract infections (UTIs) and select instances of pneumonia. Originating from Advanz Pharma's innovative

How Did Pfizer's Social Media Post Violate UK Regulations?
Management & Regulatory How Did Pfizer's Social Media Post Violate UK Regulations?

The intersection of social media and pharmaceutical regulation hit a flashpoint when Pfizer, a leading company in COVID-19 vaccine development, faced repercussions for a seemingly innocuous tweet. While social networks provide a powerful platform for sharing news and advancements, they also raise

How Is AI Changing Cardiac Imaging with Handheld Ultrasounds?
Tech & Innovation How Is AI Changing Cardiac Imaging with Handheld Ultrasounds?

Revolutionizing Point of Care Diagnostics Artificial Intelligence (AI) is rapidly transforming the medical field, with one of its most significant impacts being in the domain of cardiac imaging. The integration of AI technology with handheld ultrasound devices is enabling clinicians to perform

Hispanic Children's Leukemia Linked to Ancient Genetic Mutation
Research & Development Hispanic Children's Leukemia Linked to Ancient Genetic Mutation

Genetic Link to B-cell Acute Lymphoblastic Leukemia The Prevalence in Hispanic/Latino Children A pioneering study by the Dana-Farber Cancer Institute has unveiled insights into the increased prevalence of B-cell acute lymphoblastic leukemia (ALL) in Hispanic/Latino children. Employing a genome-wide

Revolutionizing Crop Breeding with Big Data in DWReml Software
Research & Development Revolutionizing Crop Breeding with Big Data in DWReml Software

The University of Wollongong statisticians are revolutionizing agricultural biotech with their DWReml software. This cutting-edge tool excels in analyzing large-scale, complex data from crop breeding experiments that span many years and environments. DWReml meets the modern grower's need for rapid

Aurigene Launches AI-Driven Drug Discovery Platform Aurigene.AI
Research & Development Aurigene Launches AI-Driven Drug Discovery Platform Aurigene.AI

The pharmaceutical sector is currently undergoing a pivotal shift with the introduction of Aurigene.AI by Aurigene Pharmaceutical Services. This advanced platform stands at the forefront of drug discovery, potentially revolutionizing the way new medicines are developed. The integration of

Fierce JPM Week: A Roundup of Biopharma’s Biggest Week
Editorial Fierce JPM Week: A Roundup of Biopharma’s Biggest Week

For the biopharma industry, the start of the year holds one of the biggest events in the global industry calendar, JPM Week. It’s the ultimate meeting of minds, bringing together scientists, pharmaceutical industry professionals, bankers, investors, startup founders, journalists, and media. It sets

Biopharma in 2023: Explore Seven Significant Trends
Editorial Biopharma in 2023: Explore Seven Significant Trends

The biopharma industry is rapidly evolving and advancing in 2023. According to the Pharmaceutical Manufacturing Market Size report, its overall growth will continue at a rate of 11.34% from 2021 to 2028 . However, while the industry has long been labeled as recession-proof, organizations must stay

Loading
Latest Articles

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later